Leonie Saft

<i>TP53</i> Mutations in Low-Risk Myelodysplastic Syndromes With del(5q) Predict Disease Progression

Martin Jädersten, Leonie Saft, Alexander Smith et al. · Journal of Clinical Oncology · 2011 · 457 citations · Full text

Multicenter validation of a reproducible flow cytometric score for the diagnosis of low-grade myelodysplastic syndromes: results of a European LeukemiaNET study

Matteo Giovanni Della Porta, Cristina Picone, Cristiana Pascutto et al. · Haematologica · 2012 · 165 citations · Full text

p53 protein expression independently predicts outcome in patients with lower-risk myelodysplastic syndromes with del(5q)

Leonie Saft, Masoud Karimi, Mehran Ghaderi et al. · Haematologica · 2014 · 132 citations · Full text

Clonal heterogeneity in the 5q- syndrome: p53 expressing progenitors prevail during lenalidomide treatment and expand at disease progression

Martin Jädersten, Leonie Saft, Andrea Pellagatti et al. · Haematologica · 2009 · 103 citations · Full text

Hematological Malignancy, Clonal Heterogeneity, Autoimmune Disease +15

Immunophenotypic analysis of erythroid dysplasia in myelodysplastic syndromes. A report from the IMDSFlow working group

Theresia M. Westers, Eline M.P. Cremers, Uta Oelschlaegel et al. · Haematologica · 2016 · 96 citations · Full text